{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:51:25Z","timestamp":1793613085066,"version":"4.5.0"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aapm.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Applied Clin Med Phys"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Evaluate a cone\u2010beam computed tomography (CBCT)\u2010based daily adaptive platform in cervical cancer for multiple endpoints: (1) physics contouring accuracy of daily CTVs, (2) CTV coverage with adapted plans and reduced PTV margins versus non\u2010adapted plans with standard\u2010of\u2010care (SOC) margins, (3) dosimetric improvements to CTV and organs\u2010at\u2010risk (OARs), and (4) on\u2010couch time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and materials<\/jats:title><jats:p>Using a Varian Ethos\u2122 emulator and KV\u2010CBCT scans, we simulated the doses 15 retrospective cervical cancer patients would have received with\/without online adaptation for five fractions. We compared contours and doses from SOC plans (5\u201315\u00a0mm CTV\u2010to\u2010PTV margins) to adapted plans (3\u00a0mm margins). Auto\u2010segmented CTVs and OARs were reviewed and edited by trained physicists. Physics\u2010edited targets were evaluated by an oncologist. Time spent reviewing and editing auto\u2010segmented structures was recorded. Metrics from the CTV (D99%), bowel (V45Gy, V40Gy), bladder (D50%), and rectum (D50%) were compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The physician approved the physics\u2010edited CTVs for 55\/75 fractions; 16\/75 required reductions, and 4\/75 required CTV expansions. CTVs were encapsulated by unadapted, SOC PTVs for 56\/75 (72%) fractions\u2014representative of current clinical practice. CTVs were completely covered by adapted 3\u00a0mm PTVs for 71\/75 (94.6%) fractions. CTV D99% values for adapted plans were comparable to non\u2010adapted SOC plans (average difference of \u22120.9%), while all OAR metrics improved with adaptation. Specifically, bowel V45Gy and V40Gy decreased on average by 87.6 and 109.4 cc, while bladder and rectum D50% decreased by 37.7% and 35.8%, respectively. The time required for contouring and calculating an adaptive plan for 65\/75 fractions was less than 20 min (range: 1\u201329 min).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Improved dose metrics with daily adaption could translate to reduced toxicity while maintaining tumor control. Training physicists to perform contouring edits could minimize the time physicians are required at adaptive sessions improving clinical efficiency. All emulated adaptive sessions were completed within 30 min however extra time will be required for patient setup, image acquisition, and treatment delivery.<\/jats:p><\/jats:sec>","DOI":"10.1002\/acm2.13783","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T10:44:52Z","timestamp":1665225892000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Dosimetric and feasibility evaluation of a CBCT\u2010based daily adaptive radiotherapy protocol for locally advanced cervical cancer"],"prefix":"10.1002","volume":"24","author":[{"given":"Daniela","family":"Branco","sequence":"first","affiliation":[{"name":"Department of Radiation Medicine and Applied Sciences University of California San Diego  3855 Health Sciences Drive, #0865 La\u00a0Jolla California USA"},{"name":"California Protons Cancer Therapy Center  San Diego California United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Mayadev","sequence":"additional","affiliation":[{"name":"California Protons Cancer Therapy Center  San Diego California United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Moore","sequence":"additional","affiliation":[{"name":"California Protons Cancer Therapy Center  San Diego California United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia","family":"Ray","sequence":"additional","affiliation":[{"name":"California Protons Cancer Therapy Center  San Diego California United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,10,8]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21628"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.2.74"},{"key":"e_1_2_8_4_1","unstructured":"cancer.org.Cervical Cancer Statistics.https:\/\/www.cancer.org\/cancer\/cervical\u2010cancer\/about\/key\u2010statistics.html(accessed Apr. 25 2021)"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2017.04.010"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360\u20103016(01)02785\u20107"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.06.041"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.04.041"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360\u20103016(03)00325\u20100"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167\u20108140(99)00068\u20107"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.07.009"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360\u20103016(02)02953\u2010X"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.09.060"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2004.01.005"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.06.003"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJROBP.2003.09.060"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2008.04.016"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2015.08.034"},{"key":"e_1_2_8_19_1","unstructured":"\u201cUniversity of California DiegoS.Intensity modulated radiation therapy with cisplatin and gemcitabine to treat locally advanced cervical carcinoma.https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01554410?term=gemcitabine+cervical+cancer&rank=9"},{"key":"e_1_2_8_20_1","unstructured":"\u201cUniversity of California DiegoS.Study with intensity modulated radiation therapy with cisplatin to treat stage I\u2010IVA cervical cancer.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01554397?term=intertecc&rank=1"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.06.1352"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.08.075"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2012.194"},{"issue":"2","key":"e_1_2_8_24_1","first-page":"77","article-title":"Making on\u2010line adaptive radiotherapy possible using artificial intelligence and machine learning for efficient daily re\u2010planning","volume":"8","author":"Archambault Y","year":"2020","journal-title":"Med Phys"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13399"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRO.2020.12.004"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13014\u2010021\u201001866\u20107"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13425"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13479"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/143020"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.12.012"}],"container-title":["Journal of Applied Clinical Medical Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acm2.13783","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acm2.13783","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aapm.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acm2.13783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T11:06:34Z","timestamp":1692443194000},"score":1,"resource":{"primary":{"URL":"https:\/\/aapm.onlinelibrary.wiley.com\/doi\/10.1002\/acm2.13783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1002\/acm2.13783"],"URL":"https:\/\/doi.org\/10.1002\/acm2.13783","archive":["Portico"],"relation":{},"ISSN":["1526-9914","1526-9914"],"issn-type":[{"value":"1526-9914","type":"print"},{"value":"1526-9914","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,8]]},"assertion":[{"value":"2022-02-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13783"}}